Calendar Candel Therapeutics, Inc.

Equities

CADL

US1374041093

Market Closed - Nasdaq 04:00:00 2024-04-23 pm EDT 5-day change 1st Jan Change
5.91 USD +6.68% Intraday chart for Candel Therapeutics, Inc. +0.34% +302.04%

Chart calendar Candel Therapeutics, Inc.

fde220414458ca15.T7TLO1fdCFG9MsME-ERsNiveVRMzw9_eVwSdtFkKUqs.KdaeCgTpbRSKXYJNtgc9G0ebZXhGpZeoZ2Lx0xU9ZM1_5b4JGulwAuJ-gg~25df243d729c871c789042a546d16c60

Upcoming events on Candel Therapeutics, Inc.

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-09-03 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-26 Q4 2024 Earnings Release (Projected)

Past events on Candel Therapeutics, Inc.

2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No - LB263
2024-03-28 08:05 am Q4 2023 Earnings Release
2024-03-27 Glioblastoma Drug Development Summit
2023-11-09 08:00 am Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number :1096
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number :1348
2023-11-03 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number :653
2023-09-11 03:00 pm H.C. Wainwright Global Investment Conference
2023-08-10 11:30 am Canaccord Genuity Growth Conference
2023-08-10 08:00 am Q2 2023 Earnings Release
2023-06-28 10:00 am Annual General Meeting
2023-06-07 04:00 pm Jefferies Global Healthcare Conference
2023-06-04 09:00 am American Society of Clinical Oncology Conference - Charu Aggarwal
2023-05-19 11:00 am American Society of Gene Cell Therapy Meeting - Francesca Barone
2023-05-11 08:00 am Q1 2023 Earnings Release
2023-03-30 08:00 am Q4 2022 Earnings Release
2023-02-08 03:20 pm Guggenheim Oncology Conference
2023-01-19 11:30 am B. Riley Securities Oncology Conference
2022-12-06 11:00 am R&D Day
2022-11-18 05:30 pm Society for Neuro-Oncology Meeting

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,13
0,03
278.79%
0,13
0,11
15.39%
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-25,5
-24,0
-6.44%
-33,9
-37,1
8.58%
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-25,7
-26,4
2.59%
-34,7
-36,4
4.57%
-38,4
-37,3
-2.92%

-46,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-36,1
-47,5
23.95%
-18,8
-21,8
13.59%
-37,9
-31,6
-20.06%

-41,6

Net income
Million USD
Released
Forecast
Spread
-36,1
-40,7
11.24%
-18,8
-21,8
13.59%
-37,9
-31,6
-20.06%

-41,6

EPS
USD
Released
Forecast
Spread
-1,91
-2,14
10.9%
-0,65
-0,70
7.75%
-1,31
-1,09
-20.18%

-0,91

Announcement Date29/03/2230/03/2328/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,03
0,02
106.67%
0,03
0,02
100%
0,03
0,00
-
0,03
0,01
200.1%
0,03
0,01
121.43%



0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
EBITDA
Million USD
Released
Forecast
Spread
-7,56
-7,45
-1.55%
-8,82
-7,64
-15.52%
-8,57
-5,76
-48.61%
-8,68
-8,19
-5.89%
-7,88














EBIT
Million USD
Released
Forecast
Spread
-7,74
-8,24
6.01%
-8,99
-10,9
17.84%
-8,75
-13,8
36.53%
-8,88
-11,7
24.23%
-8,10
-11,7
30.54%
-9,63
-10,0
3.67%
-9,58
-11,1
13.31%
-8,86
-9,90
10.49%
-10,3
-9,20
-12.15%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread












-5,08
-4,80
-5.9%



-9,61
-6,60
-45.67%
-8,44
-5,40
-56.2%
-11,1
-4,70
-136.06%
Net income
Million USD
Released
Forecast
Spread
1,60
-9,00
117.73%
-0,87
-14,2
93.85%
-4,15
-16,0
74.07%
-8,69
-16,0
45.7%
-5,08
-4,80
-5.9%



-9,61
-6,60
-45.67%
-8,44
-5,40
-56.2%
-11,1
-4,70
-136.06%
EPS
USD
Released
Forecast
Spread
0,51
-0,35
244.58%
-0,03
-0,34
91.1%
-0,14
-0,45
69.12%
-0,30
-0,36
16.48%
-0,17
-0,31
44.33%
-0,30
-0,35
14.29%
-0,33
-0,30
-10%
-0,29
-0,19
-52.63%
-0,38
-0,16
-137.5%
Announcement Date29/03/2212/05/2205/08/2210/11/2230/03/2311/05/2310/08/2309/11/2328/03/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CADL Stock
  4. Calendar Candel Therapeutics, Inc.